From: Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study
Characteristicsa | Antipsychotic non-users N = 292 | Antipsychotic users N = 208 | p |
---|---|---|---|
Age, years | 58 (45–66) | 59 (49–69) | 0.14 |
Female, N (%) | 141 (48.3) | 95 (45.7) | 0.56 |
Caucasian, N (%) | 248 (84.9) | 191 (91.8) | 0.08 |
Baseline cognitive impairment, N (%)b | 30 (10.3) | 29 (13.9) | 0.21 |
Charlson Comorbidity Index | 2 (1–4) | 2 (1–4) | 0.33 |
APACHE II score at study enrollment | 25 (18–31) | 26 (22–32) | 0.10 |
SOFA score at study enrollment | 9 (7–13) | 10 (7–12) | 0.52 |
ICU type, N (%) | 0.22 | ||
Medical | 183 (62.7) | 119 (57.2) | |
Surgical | 109 (37.3) | 89 (42.8) | |
ICU admission diagnoses, N (%) | 0.29 | ||
Sepsis/ARDS | 83 (28.4) | 77 (37.0) | |
Surgeryc | 65 (22.2) | 43 (20.7) | |
CHF/MI/arrhythmia | 59 (20.2) | 23 (11.1) | |
Altered mental status | 37 (12.7) | 26 (12.5) | |
COPD/asthma | 14 (4.8) | 5 (2.4) | |
Otherd | 34 (11.6) | 34 (16.3) | |
Mechanical ventilation at enrollment, N (%) | 243 (83.2) | 193 (92.8) | 0.002 |
ICU length of stay, days | 3 (2–6) | 9 (4–14) | <0.0001 |
Delirium | |||
Prevalence during study period, N (%) | 178 (61.0) | 193 (92.8) | <0.0001 |
Duration, days | 1 (0–3) | 5 (2–8) | <0.0001 |